24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels: A Prospective, Multicenter, Double-Blind, Placebo-Controlled Randomized Trial

Clinical trial NCT06014060 · RECRUITING

Trial details

NCT number: NCT06014060
Sponsor: China National Center for Cardiovascular Diseases
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Elevated Lipoprotein(a) Level Coronary Artery Disease Drug-Eluting Stent Dual Antiplatelet Therapy

Start date: 2025-06-20
Primary completion: 2028-12-31
Enrollment: 3300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.